Comprehensive Study Guide to Peripheral Nervous System Pharmacology

Basic Principles of Neuropharmacology

  • Definition and Scope:

    • Neuropharmacology: The study of drugs that alter processes controlled by the nervous system.

    • Mechanism: These drugs produce their effects by either mimicking or suppressing neuronal activity.

    • Broad Categories:

      • Peripheral Nervous System (PNS) drugs.

      • Central Nervous System (CNS) drugs.

  • Clinical Significance:

    • Neuropharmacologic agents are utilized to treat a variety of conditions, including:

      • Depression.

      • Epilepsy.

      • Hypertension.

      • Asthma.

    • Importance: Over 25%25\% of pharmaceutical texts are typically dedicated to neuropharmacologic drugs due to their ability to influence a wide range of bodily processes via neuronal regulation.

Mechanisms of Neuronal Regulation

  • Neuronal Process Overview: Neurons regulate physiological processes through two primary mechanisms:

    1. Axonal Conduction: The process of conducting an action potential down the length of the axon.

    2. Synaptic Transmission: The transfer of information across the synaptic gap through neurotransmitter release and receptor binding.

  • Sites of Drug Action:

    • Axonal Conduction (Non-selective): Drugs that act here affect all nerves regardless of their function. This lack of selectivity limits their clinical application.

      • Example: Local anesthetics decrease axonal conduction, suppressing transmission in every nerve they reach.

    • Synaptic Transmission (Highly Selective): Most neuropharmacologic agents target synaptic transmission. Because synapses vary in their neurotransmitters and receptors, drugs can be designed to target specific physiological processes.

  • Receptor Activity: Neurons influence target cells by altering receptor activity through neurotransmitter release. Drugs work by mimicking or influencing these receptor-level interactions.

The Five Steps of Synaptic Transmission

  1. Transmitter Synthesis: Transmitter molecules are created from precursor molecules within the neuron.

  2. Transmitter Storage: Synthesized transmitters are stored in vesicles located within the axon terminal.

  3. Transmitter Release: Triggered by an action potential, vesicles fuse with the terminal membrane and release contents into the synaptic gap.

  4. Receptor Binding: Transmitters travel across the gap and bind to receptors on the postsynaptic cell, initiating a physiological response.

  5. Termination of Transmission: The transmitter dissociates from the receptor and is removed from the synaptic gap via:

    • Reuptake: Transport back into the nerve terminal.

    • Enzymatic Degradation: Breakdown by specific enzymes (e.g., acetylcholinesterase).

    • Diffusion: Movement away from the synaptic gap.

Detailed Mechanisms of Drug Action at the Synapse

  • Step 1: Synthesis of Transmitter:

    • Increased Synthesis: Raises transmitter levels in storage vesicles, increasing receptor activation.

    • Decreased Synthesis: Lowers transmitter levels in storage vesicles, decreasing receptor activation.

    • Synthesis of "Super" Transmitters: Creation of transmitter molecules that are more effective than natural ones, increasing receptor activation.

  • Step 2: Storage of Transmitter:

    • Reduced Storage: Depletes transmitter content in vesicles, leading to decreased receptor activation when the neuron fires.

  • Step 3: Release of Transmitter:

    • Promotion of Release: Increases receptor activation (e.g., amphetamines).

    • Inhibition of Release: Decreases receptor activation (e.g., botulinum toxin).

  • Step 4: Binding to Receptor:

    • Direct Receptor Activation (Agonists): Drugs bind to and activate receptors, mimicking natural transmitters (e.g., morphine, epinephrine, insulin).

    • Enhanced Response to Transmitter (Enhancers): Drugs do not activate the receptor directly but make the natural transmitter more effective when it binds (e.g., benzodiazepines like diazepam).

    • Blockade of Transmitter Binding (Antagonists): Drugs bind to receptors to prevent natural transmitter activation (e.g., naloxone, antihistamines, metoprolol).

  • Step 5: Termination of Transmission:

    • Blockade of Transmitter Reuptake: Prevents recovery of the transmitter, keeping it in the gap longer to increase receptor activation.

    • Inhibition of Transmitter Breakdown: Prevents enzymatic degradation, increasing transmitter availability and receptor activation.

Selectivity and Learning Approach

  • Selectivity of Drug Action:

    • The existence of multiple receptor types for a single neurotransmitter allows for more selective drug effects.

    • Selective drugs can alter specific disease processes while leaving other physiological functions unaffected.

  • Systematic Learning Process for PNS Drugs:

    1. Identify the specific receptor types the drug acts upon.

    2. Understand the normal physiological response to the activation of those specific receptors.

    3. Determine if the drug increases or decreases the activation of those receptors.

  • Case Study: Isoproterenol:

    • Receptors: Acts specifically on β1\beta_1 and β2\beta_2 adrenergic receptors.

    • Normal Responses:

      • β1\beta_1: Increases heart rate and the force of cardiac contraction.

      • β2\beta_2: Causes bronchial dilation and elevates blood glucose levels.

    • Drug Effect: It increases activation of both, resulting in increased cardiac output, bronchial dilation, and hyperglycemia.

Physiology and Divisions of the Nervous System

  • Central Nervous System (CNS): Brain and spinal cord.

  • Peripheral Nervous System (PNS):

    • Somatic Motor System: Controls voluntary muscle movement via a single neuron pathway from the spinal cord to skeletal muscle.

    • Autonomic Nervous System (ANS): Regulates involuntary processes (heart, secretory glands, smooth muscles). It is further divided into:

      • Parasympathetic Nervous System.

      • Sympathetic Nervous System.

  • ANS Regulatory Functions:

    • Heart regulation.

    • Secretory glands (salivary, gastric, sweat, bronchial).

    • Smooth muscles (bronchi, blood vessels, urogenital system, GI tract).

Detailed Anatomical Pathways

  • Parasympathetic Pathway:

    • Structure: Two-neuron pathway involving preganglionic and postganglionic neurons.

    • Preganglionic Neurons: Lightly myelinated; travel from the spinal cord to the parasympathetic ganglia.

    • Postganglionic Neurons: Unmyelinated; travel from the ganglion to the effector organ.

  • Sympathetic Pathway:

    • Structure: Two-neuron pathway similar to the parasympathetic system.

    • Adrenal Medulla Exception: Acts like a modified postganglionic neuron. The preganglionic neuron releases ACh onto chromaffin cells, which then release Epinephrine directly into the bloodstream.

  • Somatic Motor Pathway:

    • Structure: Single, heavily myelinated motor neuron extending from the CNS to the skeletal muscle.

    • Site of Action: The Neuromuscular Junction (NMJ).

Functions of the Autonomic Nervous System

  • Parasympathetic Nervous System ("Rest and Digest"):

    • Slowing of the heart rate.

    • Increased gastric secretion.

    • Emptying of the bladder and bowel.

    • Focusing the eye for near vision and constricting the pupil (miosis).

    • Contracting bronchial smooth muscle.

  • Sympathetic Nervous System ("Fight or Flight"):

    • Implementing the acute stress response.

    • Increasing heart rate and blood pressure.

    • Shunting blood away from the viscera and toward skeletal muscles.

    • Dilating the bronchi (to improve oxygenation).

    • Dilating the pupils (mydriasis).

    • Mobilizing stored energy (glucose).

Neurotransmitters of the Peripheral Nervous System

  • Acetylcholine (ACh):

    • Released by all preganglionic neurons (both systems).

    • Released by all parasympathetic postganglionic neurons.

    • Released by all motor neurons to skeletal muscles.

    • Released by sympathetic postganglionic neurons serving sweat glands.

  • Norepinephrine (NE):

    • Released by almost all sympathetic postganglionic neurons (except sweat glands).

  • Epinephrine (Epi):

    • The primary transmitter released by the adrenal medulla.

  • Dopamine:

    • Primarily a CNS transmitter, but can act as a PNS transmitter in specific vasculature.

Peripheral Nervous System Receptors and Subtypes

  • Primary Receptor Types:

    1. Cholinergic Receptors: Mediate responses to Acetylcholine (ACh).

    2. Adrenergic Receptors: Mediate responses to Epinephrine and Norepinephrine.

  • Cholinergic Subtypes and Experimental Evidence:

    • Nicotinic-N (Neuronal): Located on cell bodies of all postganglionic neurons and the adrenal medulla. Promotes ganglionic transmission and Epi release.

    • Nicotinic-M (Muscle): Located on skeletal muscle. Causes contraction.

    • Muscarinic: Found on all parasympathetic target organs and sweat glands.

    • Differentiation Experiments:

      • Nicotine contracts skeletal muscle but not ciliary muscle.

      • Muscarine contracts ciliary muscle but not skeletal muscle.

      • Atropine blocks receptors in ciliary muscle only; d-tubocurarine blocks receptors in skeletal muscle only.

  • Adrenergic Subtypes:

    • α1\alpha_1 Receptors:

      • Location: Radial muscle of iris (eyes), arterioles, veins, male sex organs, prostatic capsule, and bladder trigone/sphincter.

      • Functions: Mydriasis, vasoconstriction (elevation of BP), ejaculation, and contraction of the bladder neck/prostate.

    • α2\alpha_2 Receptors:

      • Location: Presynaptic nerve terminals (PNS) and the CNS.

      • Functions: Regulates transmitter release (negative feedback) in the PNS; modulates sympathetic outflow and pain in the CNS.

    • β1\beta_1 Receptors:

      • Location: Heart and Kidney (juxtaglomerular cells).

      • Functions: Increases heart rate (chronotropy\text{chronotropy}), force of contraction (inotropy\text{inotropy}), and AV conduction velocity (dromotropy\text{dromotropy}). Triggers renin release in kidneys to elevate BP.

    • β2\beta_2 Receptors:

      • Location: Bronchial smooth muscle (lungs), uterine muscle, arterioles (heart/lungs/skeletal muscle), liver, and skeletal muscle fibers.

      • Functions: Bronchial dilation, uterine relaxation, vasodilation of essential arterioles, glycogenolysis (in liver/muscle), and enhanced skeletal muscle contraction.

    • Dopamine Receptors:

      • Location: Renal vasculature.

      • Functions: Dilates renal blood vessels, enhancing perfusion and diuresis.

Transmitter Specificity for Adrenergic Receptors

  • Epinephrine: Activates all α\alpha and β\beta receptors: α1,α2,β1,β2\alpha_1, \alpha_2, \beta_1, \beta_2. It does not activate dopamine receptors.

  • Norepinephrine: Activates α1,α2\alpha_1, \alpha_2, and β1\beta_1. It does not activate β2\beta_2 or dopamine receptors.

  • Dopamine: Activates α1,β1\alpha_1, \beta_1, and dopamine receptors. It does not activate β2\beta_2 receptors.